Literature DB >> 27494673

Global Distribution of Businesses Marketing Stem Cell-Based Interventions.

Israel Berger1, Amina Ahmad2, Akhil Bansal2, Tanvir Kapoor3, Douglas Sipp4, John E J Rasko5.   

Abstract

A structured search reveals that online marketing of stem-cell-based interventions is skewed toward developed economies including the United States, Ireland, Australia, and Germany. Websites made broad, imprecise therapeutic claims and frequently failed to detail procedures. Widespread marketing poses challenges to regulators, bioethicists, and those seeking realistic hope from therapies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Mesh：

Year:  2016        PMID： 27494673     DOI： 10.1016/j.stem.2016.07.015

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  35 in total

Review 1.  Ethical development of stem-cell-based interventions.

Authors:  Amanda MacPherson; Jonathan Kimmelman
Journal:  Nat Med       Date:  2019-07-03       Impact factor: 53.440

2.  Intramedullary cervical spinal mass after stem cell transplantation using an olfactory mucosal cell autograft.

Authors:  Claire F Woodworth; Gregory Jenkins; Jane Barron; Nanette Hache
Journal:  CMAJ       Date:  2019-07-08       Impact factor: 8.262

3.  The Shortage of Malaysian Stem Cell Ethics in Mainstream Database: a Preliminary Study.

Authors:  Gopalan Nishakanthi
Journal:  Asian Bioeth Rev       Date:  2019-11-28

4.  A Survey of Unregulated Direct-to-Consumer Treatment Centers Providing Stem Cells for Patients With Heart Failure.

Authors:  Zackary D Goff; Andrew B Kichura; John T Chibnall; Paul J Hauptman
Journal:  JAMA Intern Med       Date:  2017-09-01       Impact factor: 21.873

Review 5.  Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.

Authors:  Gerhard Bauer; Magdi Elsallab; Mohamed Abou-El-Enein
Journal:  Stem Cells Transl Med       Date:  2018-07-31       Impact factor: 6.940

6.  Off the grid.

Authors: 
Journal:  Nat Biotechnol       Date:  2016-09-08       Impact factor: 54.908

7.  Challenging misinformation and engaging patients: characterizing a regenerative medicine consult service.

Authors:  Cambray Smith; Charlene Martin-Lillie; Jennifer Dens Higano; Leigh Turner; Sydney Phu; Jennifer Arthurs; Timothy J Nelson; Shane Shapiro; Zubin Master
Journal:  Regen Med       Date:  2020-04-22       Impact factor: 3.806

8.  Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.

Authors:  Rajinder S Nirwan; Thomas A Albini; Jayanth Sridhar; Harry W Flynn; Ajay E Kuriyan
Journal:  Ophthalmology       Date:  2019-03-21       Impact factor: 12.079

Review 9.  Retinal stem cell transplantation: Balancing safety and potential.

Authors:  Mandeep S Singh; Susanna S Park; Thomas A Albini; M Valeria Canto-Soler; Henry Klassen; Robert E MacLaren; Masayo Takahashi; Aaron Nagiel; Steven D Schwartz; Kapil Bharti
Journal:  Prog Retin Eye Res       Date:  2019-09-05       Impact factor: 21.198

10.  Perspectives About Time Frames in Stem Cell Research for Multiple Sclerosis: "Time Is Brain".

Authors:  Shelly Benjaminy; Cody Lo; Andrew Schepmyer; Anthony Traboulsee; Judy Illes
Journal:  Int J MS Care       Date:  2019 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.